Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities

BACKGROUND: European mistletoe (Viscum album) products used in cancer therapy are frequently combined with other anti-cancer-drugs. Hence, potential herb-drug interactions have become a major safety concern in mistletoe therapy. METHODS: Three European mistletoe products (Helixor® A, Helixor® M and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schink, Michael, Dehus, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715639/
https://www.ncbi.nlm.nih.gov/pubmed/29202738
http://dx.doi.org/10.1186/s12906-017-2028-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715639/
https://www.ncbi.nlm.nih.gov/pubmed/29202738
http://dx.doi.org/10.1186/s12906-017-2028-1

Ejemplares similares